Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults

NCT03942406 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Pertussis
Whooping Cough

Interventions

COMBINATION_PRODUCT: BPZE1 pertussis vaccine and VaxINator(TM) Atomization Device

Sponsor

ILiAD Biotechnologies

Collaborators

[object Object]